BRIGHT GREEN CORPORATION GAINS MOMENTUM FOR THEIR “DRUGS MADE IN AMERICA” PLATFORM WITH APPROVAL FOR THE RESEARCH, PRODUCTION AND MANUFACTURING OF ALL SCHEDULE I AND SCHEDULE II PLANT-BASED DRUGS
22 févr. 2024 13h30 HE
|
Bright Green Corporation
BRIGHT GREEN CORPORATION BREAKS NEW GROUND IN DOMESTIC PHARMACEUTICAL PRODUCTION GRANTS, N.M., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the...
JT Medical Announces the Company is Accepting New MOUs in Addition to Its Current Two
28 oct. 2021 15h34 HE
|
JT Medical
MAYFIELD, Pa., Oct. 28, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- JT Medical (the “Company”), JT Medical announces that it is now accepting memorandums of understanding (MOUs) from researchers...